Candidate InO doses and schedules
| Dose level . | Dosing Schedule,* mg/m2 . | Total dose per cycle, mg/m2 . | |||
|---|---|---|---|---|---|
| Day 1 . | Day 8 . | Day 15 . | Day 21 . | ||
| −2 | 0.4 | 0 | 0.4 | BM evaluation performed for disease assessment | 0.8 |
| −1 | 0.6 | 0 | 0.4 | BM evaluation performed for disease assessment | 1.0 |
| 1 | 0.8 | 0 | 0.4 | BM evaluation performed for disease assessment | 1.2 |
| 2 | 0.8 | 0.4 | 0.4 | BM evaluation performed for disease assessment | 1.6 |
| 3 | 0.8 | 0.5 | 0.5 | BM evaluation performed for disease assessment | 1.8 |
| 4 | 1.0 | 0.5 | 0.5 | BM evaluation performed for disease assessment | 2.0 |
| Dose level . | Dosing Schedule,* mg/m2 . | Total dose per cycle, mg/m2 . | |||
|---|---|---|---|---|---|
| Day 1 . | Day 8 . | Day 15 . | Day 21 . | ||
| −2 | 0.4 | 0 | 0.4 | BM evaluation performed for disease assessment | 0.8 |
| −1 | 0.6 | 0 | 0.4 | BM evaluation performed for disease assessment | 1.0 |
| 1 | 0.8 | 0 | 0.4 | BM evaluation performed for disease assessment | 1.2 |
| 2 | 0.8 | 0.4 | 0.4 | BM evaluation performed for disease assessment | 1.6 |
| 3 | 0.8 | 0.5 | 0.5 | BM evaluation performed for disease assessment | 1.8 |
| 4 | 1.0 | 0.5 | 0.5 | BM evaluation performed for disease assessment | 2.0 |
Each cycle was 28 d (≤6 cycles).